ImmunityBio (NasdaqGS:IBRX) Q4 2025 Earnings call March 03, 2026 04:30 PM ET Company ParticipantsClara Dong - VP, Equity Research in BiotechnologyJason Kolbert - Managing Director, Head of Equity ResearchPatrick Soon-Shiong - Founder, Executive Chairman, and Global Chief Scientific and Medical OfficerRichard Adcock - President and CEOConference Call ParticipantsAndres Maldonado - Senior Biotechnology AnalystEdward Tenthoff - Biotech Equity Research AnalystJeet Mukherjee - VP and Biotechnology AnalystOperato ...